Literature DB >> 15350701

Transport of angiotensin peptides across the Caco-2 monolayer.

Hui-Lee Chua1, Seetharama Jois, Meng-Kwoon Sim, Mei-Lin Go.   

Abstract

The bidirectional transport of the angiotensin peptides--des-Asp-angiotensin I (DAAI), angiotensins III and IV--were studied using human intestinal Caco-2 monolayers. The peptides had low permeability rates but were relatively stable to enzymatic hydrolysis. DAAI was transported by diffusion while angiotensins III and IV were transported by an energy requiring, carrier-mediated process. The physicochemical properties and solution conformations of the peptides were investigated in an attempt to establish structure-transport correlations. Among the three peptides, DAAI was the most hydrophobic, had the highest hydrogen bonding potential and was the only peptide to have a random solution conformation, as determined from circular dichroism, two-dimensional (1)H NMR and molecular modelling. On the other hand, the more hydrophilic angiotensin IV had less hydrogen bonding potential and a solution conformation characterized by a beta turn. These factors may influence the transport characteristics of DAAI and angiotensin IV.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15350701     DOI: 10.1016/j.peptides.2004.06.009

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  5 in total

1.  Identification and characterization of a functional mitochondrial angiotensin system.

Authors:  Peter M Abadir; D Brian Foster; Michael Crow; Carol A Cooke; Jasma J Rucker; Alka Jain; Barbara J Smith; Tyesha N Burks; Ronald D Cohn; Neal S Fedarko; Robert M Carey; Brian O'Rourke; Jeremy D Walston
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-18       Impact factor: 11.205

2.  Central administration of angiotensin IV rapidly enhances novel object recognition among mice.

Authors:  Jason J Paris; Shainnel O Eans; Elisa Mizrachi; Kate J Reilley; Michelle L Ganno; Jay P McLaughlin
Journal:  Neuropharmacology       Date:  2013-02-14       Impact factor: 5.250

3.  Bioavailability of Orally Administered Des-Aspartate-Angiotensin I in Human Subjects.

Authors:  Kok-Onn Lee; Edmund Feng Tian; Martin Hui Cai; Hong Wang; Yiong-Huak Chan; Meng-Kwoon Sim
Journal:  Drugs R D       Date:  2018-03

4.  Enzymatic hydrolysis and microbial fermentation: The most favorable biotechnological methods for the release of bioactive peptides.

Authors:  Dora Elisa Cruz-Casas; Cristóbal N Aguilar; Juan A Ascacio-Valdés; Raúl Rodríguez-Herrera; Mónica L Chávez-González; Adriana C Flores-Gallegos
Journal:  Food Chem (Oxf)       Date:  2021-10-23

5.  A Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Orally Administered Des-Aspartate Angiotensin I in Healthy Subjects.

Authors:  Ko-Onn Lee; Chin-Meng Khoo; Balram Chowbay; Yiong-Huak Chan; Meng-Kwoon Sim
Journal:  Drugs R D       Date:  2016-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.